Home » Topics » Regulatory » Patents

Patents
RSS

Ajinomoto claims antivirals

April 26, 1996

Takeda claims novel carbapenems

April 26, 1996

SKB claims morphinoid derivatives

April 26, 1996

Taisho reports 5-HT4 agonists for GI disorders

April 19, 1996

Byk Gulden researches anti-Helicobacter agents

April 19, 1996

More antiplatelet agents from Thomae

April 19, 1996

Antiplatelet agents emerging from the Thomae pipeline

April 19, 1996

New series of thrombin inhibitors claimed by Thomae

April 19, 1996

SKB discloses NK3 antagonists in patent literature

April 19, 1996

Nikken Chemicals describes antiallergy agents

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...